CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...
Phase 2
San Francisco, California, United States
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Walnut Creek, Colorado, United States of America and 98 other locations
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...
Phase 3
Palo Alto, California, United States and 30 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
San Francisco, California, United States and 221 other locations
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19.Thi-...
Phase 3
Walnut Creek, Colorado, United States of America and 18 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 3
Oakland, California, United States and 100 other locations
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...
Phase 3
Walnut Creek, Colorado, United States of America and 199 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Walnut Creek, California, United States and 94 other locations
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...
Palo Alto, California, United States and 2 other locations
This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and...
Phase 2
San Francisco, California, United States
Clinical trials
Research sites
Resources
Legal